Short Interest in Semler Scientific, Inc. (NASDAQ:SMLR) Rises By 123.3%

Semler Scientific, Inc. (NASDAQ:SMLRGet Free Report) was the recipient of a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 477,700 shares, an increase of 123.3% from the May 15th total of 213,900 shares. Based on an average daily volume of 187,900 shares, the short-interest ratio is presently 2.5 days. Approximately 8.7% of the shares of the stock are short sold.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of SMLR. Quantbot Technologies LP bought a new position in Semler Scientific during the 3rd quarter valued at approximately $57,000. AJOVista LLC bought a new position in Semler Scientific during the 4th quarter valued at approximately $58,000. Tower Research Capital LLC TRC raised its position in Semler Scientific by 250.5% during the 4th quarter. Tower Research Capital LLC TRC now owns 2,103 shares of the company’s stock valued at $93,000 after purchasing an additional 1,503 shares during the last quarter. Nkcfo LLC bought a new position in Semler Scientific during the 4th quarter valued at approximately $177,000. Finally, BOKF NA bought a new position in Semler Scientific during the 1st quarter valued at approximately $227,000. Institutional investors own 49.37% of the company’s stock.

Semler Scientific Stock Performance

Shares of NASDAQ SMLR remained flat at $38.32 during midday trading on Friday. The stock had a trading volume of 533,750 shares, compared to its average volume of 162,075. Semler Scientific has a 12 month low of $20.88 and a 12 month high of $53.38. The company’s 50 day simple moving average is $27.27 and its two-hundred day simple moving average is $36.61. The company has a market cap of $270.92 million, a PE ratio of 13.85 and a beta of 0.96.

Semler Scientific (NASDAQ:SMLRGet Free Report) last released its earnings results on Tuesday, May 7th. The company reported $0.78 earnings per share for the quarter. Semler Scientific had a return on equity of 30.36% and a net margin of 32.92%. The company had revenue of $15.90 million during the quarter.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the company. TheStreet raised Semler Scientific from a “c+” rating to a “b-” rating in a research note on Friday, March 1st. Lake Street Capital raised Semler Scientific to a “strong-buy” rating in a research note on Wednesday, May 8th.

View Our Latest Research Report on SMLR

Semler Scientific Company Profile

(Get Free Report)

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

Further Reading

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.